Oct 10, 2023 Egetis Therapeutics has secured approximately SEK 462 million in a combined financing comprising a SEK 172 million equity private placement and SEK 290 million debt financing
Sep 12, 2023 1847 Subsidiary, ICU Eyewear, Successfully Completes Refinancing and Upsizing of $15 Million Revolving Credit Facility
Aug 24, 2023 Foremost Lithium Announces Closing of USD $4.0 Million Public Offering and NASDAQ Listing
